CE: Nursing in the fourth decade of the HIV epidemic

Whitney Marie Starr¹, Lucy Bradley Springer

• ¹Whitney Marie Starr is an assistant professor and Lucy Bradley-Springer is an associate professor in the Division of Infectious Diseases at the University of Colorado Denver School of Medicine in Aurora. Whitney Marie Starr has served as a consultant for Gilead Sciences, a manufacturer of drugs for infectious diseases, some of which are discussed in this article. Lucy Bradley-Springer received a grant from the Health Resources and Services Administration to fund the Mountain Plains AIDS Education and Training Center, a program initiated in 1988 to educate health care providers in eight states about HIV infection. Through the Intergovernmental Personnel Act Mobility Program, she works with the Centers for Disease Control and Prevention to teach health coaches in six clinics throughout the country about ways to help HIV-infected patients prevent HIV transmission, remain in care, and practice medication adherence. She owns stock in Johnson and Johnson and Merck. Products manufactured by these companies are discussed in this article. Contact author: Lucy Bradley-Springer, lucy.bradley-springer@ucdenver.edu. AJN's peer review process has determined this article to be objective and free of commercial bias. The planners have disclosed no potential conflicts of interest, financial or otherwise.